Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Mar;49(3):349–356. doi: 10.1038/bjc.1984.55

Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.

A N Akbar, D B Jones, D H Wright
PMCID: PMC1976757  PMID: 6231045

Abstract

Indirect evidence suggests that abnormal regulation of B cells exists in Hodgkin's disease (HD) due, perhaps, to the sequestration of regulatory T-lymphocyte subpopulations in the spleen in this condition. Other work implicates the B-cell itself in this abnormality. In this study we have attempted to measure regulatory T-cell function by quantitating spontaneous and Concanavalin A(Con A)-induced suppressor activity in T-enriched spleen cells from control and HD spleens for pokeweed mitogen(PWM)-induced immunoglobulin (Ig) production. Using this polyclonal system, HD patients' spleen T-lymphocytes could not be shown to differ markedly from the control series. Cells capable of spontaneous and mitogen-induced modulation of Ig synthesis were present in both populations and showed a reciprocal relationship implying the activation of the same cell type. In this respect HD and control spleen resembled peripheral blood. A limited parallel investigation of PWM-regulatory activity in cells from spleen and peripheral blood from individual patients was also undertaken. Individual patients showed wide variation in suppression between the two compartments and, therefore, measurements of functional capacity in blood alone may not provide a true estimate of total regulatory capacity in lymphoma patients.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al Sam S., Jones D. B., Payne S. V., Wright D. H. Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls. Br J Cancer. 1982 Nov;46(5):806–810. doi: 10.1038/bjc.1982.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Damle N. K., Gupta S. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies. Clin Exp Immunol. 1982 Jun;48(3):581–588. [PMC free article] [PubMed] [Google Scholar]
  3. Dwyer J. M., Johnson C. The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol. 1981 Nov;46(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  4. Engleman E. G., Benike C., Hoppe R. T., Kaplan H. S. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease. Transplant Proc. 1979 Dec;11(4):1827–1829. [PubMed] [Google Scholar]
  5. Fauci A. S., Steinberg A. D., Haynes B. F., Whalen G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978 Oct;121(4):1473–1479. [PubMed] [Google Scholar]
  6. Galili U., Klein E., Christensson B., Biberfeld P. Lymphocytes of Hodgkin's biopsies exhibit: stable E-rosette formation, natural attachment and glucocorticoid sensitivity, similar to immunoactivated T cells. Clin Immunol Immunopathol. 1980 Jun;16(2):173–179. doi: 10.1016/0090-1229(80)90201-9. [DOI] [PubMed] [Google Scholar]
  7. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  8. Haynes B. F., Fauci A. S. Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals. Cell Immunol. 1978 Mar 15;36(2):294–302. doi: 10.1016/0008-8749(78)90273-3. [DOI] [PubMed] [Google Scholar]
  9. Herscowitz H. B., Sakane T., Steinberg A. D., Green I. Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function. J Immunol. 1980 Mar;124(3):1403–1410. [PubMed] [Google Scholar]
  10. Hillinger S. M., Herzig G. P. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest. 1978 Jun;61(6):1620–1627. doi: 10.1172/JCI109082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ilfeld D., Krakauer R. S. Hydrocortisone reverses the suppression of immunoglobulin synthesis by concanavalin A-activated spleen cell supernatants. Clin Exp Immunol. 1982 Apr;48(1):244–248. [PMC free article] [PubMed] [Google Scholar]
  12. Jones D. B., Elliott E. V., Payne S. V., Wright D. H. Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients. Clin Exp Immunol. 1978 Oct;34(1):100–105. [PMC free article] [PubMed] [Google Scholar]
  13. Jones D. B., Payne S. V., Wright D. H. Anti-lymphocytic globulin in Hodgkin's disease. Biomedicine. 1977 Jul;27(5):177–178. [PubMed] [Google Scholar]
  14. Kass L., Votaw M. L. Eosinophilia and plasmacytosis of the bone marrow in Hodgkin's disease. Am J Clin Pathol. 1975 Aug;64(2):248–250. doi: 10.1093/ajcp/64.2.248. [DOI] [PubMed] [Google Scholar]
  15. Landaas T. O., Grimmer O., Heier H. E., Godal T. Increased serum IgE in Hodgkin's disease is of polyclonal origin. Acta Pathol Microbiol Scand C. 1979 Dec;87(6):377–380. [PubMed] [Google Scholar]
  16. Lipsky P. E., Ginsburg W. W., Finkelman F. D., Ziff M. Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol. 1978 Mar;120(3):902–910. [PubMed] [Google Scholar]
  17. Lobo P. I., Spencer C. E. Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems. J Clin Invest. 1979 Jun;63(6):1157–1163. doi: 10.1172/JCI109409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Longmire R. L., McMillan R., Yelenosky R., Armstrong S., Lang J. E., Craddock C. G. In vitro splenic IgG synthesis in Hodgkin's disease. N Engl J Med. 1973 Oct 11;289(15):763–767. doi: 10.1056/NEJM197310112891501. [DOI] [PubMed] [Google Scholar]
  19. Payne S. V., Jones D. B., Haegert D. G., Smith J. L., Wright D. H. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol. 1976 May;24(2):280–286. [PMC free article] [PubMed] [Google Scholar]
  20. Sakane T., Steinberg A. D., Green I. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum. 1978 Jul-Aug;21(6):657–664. doi: 10.1002/art.1780210608. [DOI] [PubMed] [Google Scholar]
  21. Sampson D., Grotelueschen C., Kauffman H. M., Jr The human splenic suppressor cell. Transplantation. 1975 Nov;20(5):362–367. doi: 10.1097/00007890-197511000-00002. [DOI] [PubMed] [Google Scholar]
  22. Schulof R. S., Bockman R. S., Garofalo J. A., Cirrincione C., Cunningham-Rundles S., Fernandes G., Day N. K., Pinsky C. M., Incefy G. S., Thaler H. T. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease. Cancer. 1981 Aug 15;48(4):964–973. doi: 10.1002/1097-0142(19810815)48:4<964::aid-cncr2820480419>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  23. Schwartz S. A., Shou L., Good R. A., Choi Y. S. Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donors. Proc Natl Acad Sci U S A. 1977 May;74(5):2099–2103. doi: 10.1073/pnas.74.5.2099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Smith C. I., Svejgaard A. Concanavalin-A-induced suppressor lymphocytes in normal individuals. Scand J Immunol. 1981;13(5):483–492. doi: 10.1111/j.1365-3083.1981.tb00160.x. [DOI] [PubMed] [Google Scholar]
  26. Souhami R. L., Babbage J., Callard R. E. Specific in vitro antibody response to varicella zoster. Clin Exp Immunol. 1981 Oct;46(1):98–105. [PMC free article] [PubMed] [Google Scholar]
  27. Sousa M. D., Yang M., Lopes-Corrales E., Tan C., Hansen J. A., Dupont B., Good R. A. Ecotaxis: the principle and its application to the study of Hodgkin's disease. Clin Exp Immunol. 1977 Jan;27(1):143–151. [PMC free article] [PubMed] [Google Scholar]
  28. Twomey J. J., Laughter A. H., Farrow S., Douglass C. C. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. doi: 10.1172/JCI108113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Twomey J. J., Laughter A. H., Rice L., Ford R. Spectrum of immunodeficiencies with Hodgkin's disease. J Clin Invest. 1980 Oct;66(4):629–637. doi: 10.1172/JCI109898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vanhaelen C. P., Fisher R. I. Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cells. J Immunol. 1981 Sep;127(3):1216–1220. [PubMed] [Google Scholar]
  31. de Sousa M., Tan C. T., Siegal F. P., Filippa D. A., Tan R., Good R. A. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease. Pediatr Res. 1978 Feb;12(2):143–147. doi: 10.1203/00006450-197802000-00016. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES